Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
| Conditions: | Malignant Mesothelioma |
| Start Date: | May 1, 2002 |
| Phase: | Phase II |
| Status: | Completed |
| NCT ID: | NCT00039182 |
| Study Type: | Interventional |
| Intervention: | Drug: erlotinib hydrochloride |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Southwest Oncology Group|National Cancer Institute (NCI) |
| Ages: | Child|Adult|Senior |
| Enrollment: | 0 |
| Funded By: | Other|NIH |
| First Received: | June 6, 2002 |
| End Date: | |
| Last Updated: | January 28, 2009 |
| Last Verified: | April 1, 2003 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
